|
|
Volumn 276, Issue 5312, 1997, Pages 520-523
|
|
AIDS trials ethics questioned
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPRENAVIR;
CD4 ANTIGEN;
DELAVIRDINE;
DIDANOSINE;
INDINAVIR;
LAMIVUDINE;
LOVIRIDE;
NELFINAVIR;
NEVIRAPINE;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
DEVELOPING COUNTRY;
DRUG SCREENING;
FOOD AND DRUG ADMINISTRATION;
IMMUNE SYSTEM;
LYMPHOCYTE COUNT;
MEDICAL ETHICS;
MORTALITY;
NOTE;
PRIORITY JOURNAL;
T LYMPHOCYTE SUBPOPULATION;
VIRUS REPLICATION;
AIDS CLINICAL TRIALS GROUP;
ALTERNATIVES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
FEDERAL GOVERNMENT;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT REGULATION;
HEALTH CARE AND PUBLIC HEALTH;
NATIONAL INSTITUTES OF HEALTH;
UNITED STATES;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-HIV AGENTS;
CONTROLLED CLINICAL TRIALS;
DRUG RESISTANCE, MICROBIAL;
DRUG THERAPY, COMBINATION;
ETHICS, MEDICAL;
FEDERAL GOVERNMENT;
GOVERNMENT REGULATION;
HIV;
HIV PROTEASE INHIBITORS;
HUMANS;
RESEARCH DESIGN;
REVERSE TRANSCRIPTASE INHIBITORS;
VIRAL LOAD;
|
|
EID: 0030978122
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.276.5312.520 Document Type: Note |
|
Times cited : (18)
|
|
References (0)
|